Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/IKT/Gross profit

Inhibikase Therapeutics, Inc. (IKT) Gross profit

Inhibikase Therapeutics, Inc. (IKT) annual gross profit history from SEC filings — each fiscal year as reported.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to IKT

Source: SEC XBRL filings · For reference only · Not investment advice

More IKT financial trends

IKT RevenueIKT Net incomeIKT Net marginIKT Gross marginIKT Operating incomeIKT Operating marginIKT Operating cash flowIKT Free cash flowIKT Capital expendituresIKT Return on equityIKT Stock buybacksIKT Dividends paidIKT Total assetsIKT Total liabilitiesIKT Shareholders’ equityIKT overview →